Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2025-12-24 @ 11:31 PM
NCT ID: NCT05252156
Eligibility Criteria: Inclusion Criteria: * Aged \>=18 years; * Diagnosed with moderate OSA; * Smartphone or tablet capable of running the eXciteOSA app; * Fluent in written and spoken English. Exclusion Criteria: * BMI \>=35 kg/m2; * Implanted medical device; * Dental braces and/or intraoral metal jewelry; * Any condition impacting the tissue of the oral cavity, including but not limited to ulceration or periodontitis; * Symptomatic nasal pathology such as septal deviation, nasal polyposis, or chronic rhinosinusitis; * Tonsillar hypertrophy (tonsil size grade 3 or greater); * Clinically significant facial or oropharyngeal abnormalities such as class 2 malocclusion; * Prior oropharyngeal surgery for sleep-disordered breathing; * At-home use of a mandibular advancement device or PAP for sleep-disordered breathing within the previous four weeks; * Use of any overnight therapy that cannot be withdrawn during study enrollment; * Diagnosed with any sleep disorder other than OSA; * Chronic use of central nervous system depressants; * Driver in a sleepiness-related vehicular accident or near-miss within the two years prior to enrolment (self-report); * Employed as a commercial driver, pilot, or other occupation that may be impacted by hypersomnolence; * Considered by the PI to be at risk of an AE resulting from hypersomnolence; * Any periods of non-connectivity (wifi or cellular data) exceeding 48 hours planned to take place, or likely to take place, during enrollment; * Current or planned pregnancy; * Member of a vulnerable population, including but not limited to prisoners and those lacking consent capacity; * Clinically-significant burden of comorbidities (including history of myocardial infarction, cardiac arrhythmia, heart failure, history of stroke, or transient ischemic attack), and/or any other limitation or condition that may impact the patient's ability to complete the study protocol and use the device per the Instructions for Use (PI discretion); * Employee and/or residing household member who is an employee of a company that produces or distributes products designed to diagnose, treat, and/or monitor sleep or sleep-disordered breathing (including the Sponsor).
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05252156
Study Brief:
Protocol Section: NCT05252156